Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Almirall

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Almirall's 2013 sales performance.

Almirall launches Sativex in Italy

Almirall launches Sativex in Italy Brings cannabis-based drug for multiple sclerosis spasticity to market. Almirall has launched its cannabinoid treatment Sativex for moderate to severe spasticity in multiple sclerosis (MS) patients in Italy.

New chief information officer at Bayer Healthcare

New chief information officer at Bayer Healthcare He succeeds Matthias Moritz, who left Bayer in March 2013 to join Almirall.

GSK submits COPD drug in US and EU

GSK submits COPD drug in US and EU Other COPD products coming through development include Boehringer Ingelheim's olodaterol, which has also received backing from an FDA panel, Novartis' QVA149 (glycopyrronium bromide and indacaterol maleate) and Forest

GSK buoyed by FDA panel backing for Advair successor

GSK buoyed by FDA panel backing for Advair successor Other COPD combinations coming through development include Boehringer Ingelheim/Pfizer's olodaterol/tiotropium, Novartis' QVA149 (glycopyrronium bromide and indacaterol maleate) and Forest Labs/Almirall's aclidinium bromide/formoterol candidate,

GW Pharma says German Sativex pricing "unacceptable"

GW Pharma says German Sativex pricing the product," said Farid Taha, the managing director of Almirall Hermal in Germany. ... We will evaluate all possible options and further steps for Sativex as Almirall believes Germany should continue as a relevant country for innovative medicines," he

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics